Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Administration Details Retatrutide is administered via subcutaneous injection once weekly
As an FDA-approved medication, tirzepatide weight loss is becoming a new standard for treating obesity and managing weight
If you're not losing weight on semaglutide, it may be due to how your body tolerates or absorbs the medicationsomething your provider can help evaluate
Dysesthesia occurred in 8.8% and 20.9% of patients treated with retatrutide compared to 0.7% with placebo
US$ 21.47
US$ 28.93
US$ 23.65
US$ 23.76
US$ 20.75
US$ 21.48
